Streetbeat News

Revenues

EWU

The U.K. Halifax House Price Index for February showed a year-over-year increase of 0.4%, which is below the estimated 0.8% and a decrease from the prior month's revised figure of 1.2%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 7:15 am

VLRS

Volaris reported a decrease in ASM capacity by 13.7% YoY in February 2024, attributed to Pratt & Whitney engine inspections causing aircraft groundings. RPMs fell by 10.9%, while the load factor increased to 85.9%. Passenger numbers dropped by 15.2% to 2.1 million. Domestic RPMs in Mexico decreased by 21.5%, but international RPMs rose by 13.2%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:46 am

FSM

Fortuna Silver Mines (NYSE:FSM) reported Q4 2023 adjusted EPS of $0.070, missing the $0.100 estimate, but sales of $265.314M exceeded the $261.000M estimate, marking a 61.09% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:11 am

FXI

China's trade balance in USD for February was reported at $125.16 billion, significantly higher than the estimated $110.30 billion and the previous month's $75.34 billion.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:34 am

FXI

China's imports for February increased by 3.5% year-over-year, surpassing the estimated 1.5% and the previous month's 0.2%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:34 am

FXI

China's exports in February increased by 7.1% year-over-year, significantly surpassing the estimated 1.9% and the previous month's 2.3% growth.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:34 am

EWA

Australia's trade balance for the reported period was AUD 11.027 billion, slightly below the estimated AUD 11.420 billion but higher than the previous period's revised figure of AUD 10.743 billion.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:33 am

MRMD

MariMed Inc (OTCQX:MRMD), a multi-state cannabis operator, reported a revenue increase to $38.9 million in Q4 2023, up from $35.8 million in the same period last year. However, the company experienced a net loss of $10.1 million in the quarter, compared to a net income of $4.7 million in the previous year, primarily due to a $10 million loss on the extinguishment of debt. For the full year, revenue was $148 million, up from $134 million in 2022, but net loss increased to $16 million from a net income of $13.6 million in 2022. CEO Jon Levine highlighted the company's sixth consecutive year of double-digit revenue growth and positive adjusted EBITDA for the fourth year. MariMed anticipates 5% to 7% revenue growth in 2024, not including potential new revenue from operations in Ohio, Missouri, Maryland, or acquisitions.

Portfolio Pulse from Maureen Meehan

March 07, 2024 | 2:09 am

BRC

BRC has projected its FY24 net revenue to be between $430M-$460M, which is below the estimated $477.64M. The company also anticipates an increase in profit and cash flow for 2024, with Adjusted EBITDA expected to be between $27.0M and $40.0M and a Free Cash Flow conversion rate of approximately 80% of Adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:55 pm

AIRG

Airgain anticipates Q1 sales to be between $13.3M-$14.7M, surpassing the estimated $11.933M. The company also expects an adjusted EPS loss of $(0.06) at the midpoint, which is better than the estimated loss of $(0.14).

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 10:51 pm